SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-019056
Filing Date
2024-04-29
Accepted
2024-04-29 16:54:25
Documents
6
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2024def14a.htm DEF 14A 697402
2 adamsignature.jpg GRAPHIC 11446
3 importantnotice2024.jpg GRAPHIC 79767
4 pvpfy2023capgraphv3.jpg GRAPHIC 158564
5 pvpfy2023graphversion3.jpg GRAPHIC 174240
6 updatedproxycard.jpg GRAPHIC 89207
  Complete submission text file 0001628280-24-019056.txt   1398967
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38295 | Film No.: 24892153
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)